FDA
-
-
-
-
-
-
-
Summit Therapeutics plc (SMMT) PT Lowered to $38 at Guggenheim
-
-
-
-
-
-
-
Canaccord on Hims and Hers: see "HIMS shares outperforming the major indices by several hundred basis points"
-
-
-
-
-
-
-
Hims & Hers Health shares jump on FDA's push to expand BPC-157 access
-
-
-
-
-
-
-
HCW Biologics requests FDA meeting for T-cell engager HCW11-018b
-
-
-
-
-
-
-
Monopar Therapeutics (MNPR) PT Raised to $125 at H.C. Wainwright
-
-
-
-
-
-
-
Arcus, AVEO to test kidney cancer drug combo in new trial
-
-
-
-
-
-
-
FDA approves GSK lung cancer drug Jideytro ahead of schedule
-
326,430 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

